Walleye Capital’s Roivant Sciences Ltd. Warrant ROIVW Stock Holding History

Walleye Capital’s Portfolio ROIVW Stock Details ROIVW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-16,744	Closed	-$41.5K	–	5530
2023 Q2	$41.5K	Sell	16,744 -299,843	-95%	-$590K	﹤0.01%	3672
2023 Q1	$462K	Buy	316,587 +299,943	+1,802%	+$557K	0.01%	1786
2022 Q4	$32.3K	Sell	16,644 -104,700	-86%	-$115K	﹤0.01%	2596
2022 Q3	$47K	Buy	121,344 +38,135	+46%	+$20.3K	﹤0.01%	2597
2022 Q2	$50K	Buy	83,209 +66,565	+400%	+$34.8K	﹤0.01%	1824
2022 Q1	$15K	Sell	16,644 -30,000	-64%	-$38.1K	﹤0.01%	2027
2021 Q4	$95K	Buy	+46,644	New	+$71.2K	﹤0.01%	1699

Walleye Capital's ROIVW Position: Q3 2023 in Review

Walleye Capital sold out of Roivant Sciences Ltd. Warrant (ROIVW) in Q3 2023, closing a stake of 16,744 shares — an estimated $41.5K sold.

Walleye Capital first reported a position in ROIVW in Q4 2021 and held it in 7 quarters. The position peaked at $462K in Q1 2023. 0 funds tracked by Wall St. Rank hold ROIVW as of Q3 2023.

Walleye Capital reported no remaining Roivant Sciences Ltd. Warrant position as of Q3 2023 after selling out during the quarter.
Walleye Capital sold 16,744 Roivant Sciences Ltd. Warrant shares in Q3 2023, an estimated $41.5K.
Walleye Capital first reported a position in Roivant Sciences Ltd. Warrant in Q4 2021 and held it in 7 quarters.
Walleye Capital's Roivant Sciences Ltd. Warrant position peaked at $462K in Q1 2023.
0 funds tracked by Wall St. Rank held Roivant Sciences Ltd. Warrant as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.